loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: CAS-159351-69-6

    Menu

    CAS-159351-69-6

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 263,673Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22334 / DOSAGE - TABLET;ORAL - 2.5MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EVEROLIMUS(UNII: 9HW64Q8G6G)
    (EVEROLIMUS - UNII:9HW64Q8G6G)     		EVEROLIMUS7.5mg | 2mg | 3mg | 10mg | 2.5mg | 5mg | 5mg

    Inactive Ingredients

    Ingredient Name
    Biocon Pharma Inc.
    Novartis Pharmaceuticals Corporation
    Par Pharmaceutical, Inc.
    ANHYDROUS LACTOSE(3SY5LH9PMK)
    BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)  
    CROSPOVIDONE(2S7830E561) 
    CROSPOVIDONE(68401960MK)  
    HYPROMELLOSE 2208 (3 MPA.S)(9H4L916OBU)  
    HYPROMELLOSE 2910 (3 MPA.S)(0VUT3PMY82)  
    HYPROMELLOSES(3NXW29V3WO)  
    LACTOSE MONOHYDRATE(EWQ57Q8I5X) 
    MAGNESIUM STEARATE(70097M6I30)
    MANNITOL(3OWL53L36A)  
    SILICON DIOXIDE(ETJ7Z6XBU4)